Skip to content
Vivos Primêre Funksje: Eachchirurgysysteem by Olcayto Guelec and David Geuder
Vivos Primêre Funksje: Eachchirurgysysteem by Olcayto Guelec and David Geuder
Vivos Primêre Funksje: Eachchirurgysysteem by Olcayto Guelec and David Geuder
Vivos Primêre Funksje: Eachchirurgysysteem by Olcayto Guelec and David Geuder
Vivos Primêre Funksje: Eachchirurgysysteem by Olcayto Guelec and David Geuder

Goud Medysk Produkt · 2026

Vivos Primêre Funksje: Eachchirurgysysteem

by Olcayto Guelec and David Geuder

  • A' Design Award yn Goud 2026 in Medysk Produkt
  • CLIENT: Geuder AG
  • Estimated Number of Design Views: 53,358
  • Verification code 7DEB548122 · Verify this award
Email this page

Colors

About Vivos Primêre Funksje: Eachchirurgysysteem

Boektekst: Vivos definiearret it chirurgyske wurkstasjon opnij as in platfoarm dat mei de klinyske ambysje meiûntwikkelet. Trije konfiguraasjes, Core, Nova en Nova+, wreidzje de mooglikheden út sûnder it systeem te ferfangen, de iennichste opwurdearringsarsjitektuer fan syn soarte yn eachchirurgy. Ien inkeld ynterface, falidearre op 91,7 prosint tefredenheid by earste gebrûk sûnder foarôfgeande training, wjerspegelet in ûntwerp dat om de sjirurch hinne boud is ynstee fan om de proseduere. Ferljochte ynstrumintferbiningen, ferfine materialen en beheinde detaillearring jouwe it apparaat in rêstige en selsbewuste útstrieling, frij fan it fisuele lûd dat typysk is foar de kategory.

About the A' Design Award yn Goud

Vivos Primêre Funksje: Eachchirurgysysteem is in winner fan de A' Design Award yn Goud, in ekstreem prestisjeuze erkenning foar earste-klas, prachtige en treflike ûntwerpen. Goudwinners binne tige ynnovative, fisionêre en glamoureus ferbjusterjende skeppings dy't it sjeny, de wiisheid en de feardigens fan har ûntwerpers wjerspegelje. Fan Vivos Primêre Funksje: Eachchirurgysysteem wurdt ferwachte dat it in tige priizge, trendsettende en monumintale útfining is dy't unferlykbere wearde leveret. Dit winnende ûntwerp fan de A' Design Award yn Goud is in spektakulêr, respektearre projekt dat grutte foardielen bringt en de grinzen fan keunst, wittenskip, ûntwerp en technology ferleget. Vivos Primêre Funksje: Eachchirurgysysteem makket yntinse gefoelens fan begearte, stekt passy oan, stimulearret kreativiteit en fassinearret ús.

Press Kit

Unique Properties
Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensions & Packaging
Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Tags
Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Production Technology
Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Design Challenge
The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Research
Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiration
Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Project Duration
The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Operation Flow
Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Patents
Design copyright: Geuder AG, 2026. Patent application pending. All rights reserved.
Image Credits
Photography Geuder AG, 2026

Related Designs

View All

Good Design Deserves Great Recognition

Nominate Your Work for the A' Design Award.

Nominate